Personal information
Verified email domains
Biography
Dr Morgan completed his BSc in Biomedical Science at the University of Portsmouth (2004-2007) before completing a PhD in leukaemia research at Cardiff University (2007-2011) in the world leading Haematology department headed by Professor Alan Burnett. His thesis examined the role of a Wnt signalling protein (gamma-catenin) in acute myeloid leukaemia (AML) under the supervision of Professors Alex Tonks and Richard Darley.
From here Rhys joined the School of Cellular & Molecular Medicine at the University of Bristol in 2013 to pursue his interests in signal transduction and cancer biology. Under the supervision of Professors Christos Paraskeva and Ann Williams he undertook post-doctoral studies investigating the role of the stem cell marker LGR5 and Wnt/EGF signal transduction in colorectal cancer.
In 2016, whilst at the University of Bristol, Rhys was awarded a prestigious Kay Kendall Leukaemia Fund (KKLF) Junior Fellowship to examine the Wnt/beta-catenin signalling in AML. In 2018 Dr Morgan joined the Department of Biochemistry and Biomedicine at the School of Life Sciences, University of Sussex to establish his own leukaemia research group.
From July 2019 he assumed the role of Lecturer in Biomedical Science and continues his research interests in cell signalling and leukaemia. Dr Morgan is now Director of the Haematology Research Group, a group he established in 2019 to bring together researchers from the School of Life Sciences and Brighton and Sussex Medical School with shared haematological research interests. Rhys was promoted to Associate Professor of Cancer Biology in October 2022.
Activities
Employment (6)
Education and qualifications (2)
Professional activities (4)
Funding (6)
KKL1446
RG160682
34725/startup
KKL1051